Gene · 2798
Papers2,995
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,995
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and genetic basis of congenital gonadotropin deficiency. | Hum Reprod Open | 2026 | 41873429 | PubTator, text mining | PubMed |
| Activation of L-histidine biosynthesis as a new antibiotic strategy against Mycobacterium tuberculosis. | Nat Commun | 2026 | 41864986 | PubTator, text mining | PubMed |
| Retrospective analysis of growth hormone effects on growth and adenoma volume in children with pituitary microadenoma. | Transl Pediatr | 2026 | 41810173 | PubTator, text mining | PubMed |
| Development of a novel NanoBRET high-throughput drug screening assay for human GnRH receptor using sulfo-cyanine 5 fluorophore. | J Pharm Anal | 2026 | 41798066 | PubTator, text mining | PubMed |
| Novel KISS1 Gene Mutation Leading to Male Hypogonadotropic Hypogonadism. | Exp Clin Endocrinol Diabetes | 2026 | 41786302 | PubTator, text mining | PubMed |
| Updated compendium of genes and variants associated with congenital hypogonadotropic hypogonadism: systematic review, classification pipeline, and network analysis. | Hum Mol Genet | 2026 | 41758602 | PubTator, text mining | PubMed |
| Inflammation and Oxidative-Stress Pathways Are Associated with Idiopathic Sudden Hearing Loss: A Genome-Wide Association Study in 15,494 Japanese Individuals. | Int J Mol Sci | 2026 | 41751972 | PubTator, text mining | PubMed |
| Nanoplatforms for Multimodal Imaging and Targeted Cancer Therapy: Recent Advances and Future Perspectives. | Bioengineering (Basel) | 2026 | 41749714 | PubTator, text mining | PubMed |
| Hormonal Modulation of Keratoconus: A Systematic Review and Screening Strategy for At-Risk Populations. | Ophthalmol Sci | 2026 | 41732592 | PubTator, text mining | PubMed |
| Sex hormone-psoriasis interactions: from sex-specific clinical features to immunoregulatory mechanisms. | Front Immunol | 2026 | 41727453 | PubTator, text mining | PubMed |
| Impact of estroprogestin therapies on bone health from adolescence to postmenopause. | J Endocrinol Invest | 2026 | 41706416 | PubTator, text mining | PubMed |
| A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells. | MedComm (2020) | 2026 | 41700173 | PubTator, text mining | PubMed |
| Atypical gelation of Elagolix sodium in aqueous media: Mechanistic insights and Inhibition via coamorphization. | Eur J Pharm Biopharm | 2026 | 41690332 | PubTator, text mining | PubMed |
| Safety, pharmacokinetics, and sex hormone suppression of LY01021 versus relugolix: A single- and multiple-dose escalation study. | Eur J Pharmacol | 2026 | 41654161 | PubTator, text mining | PubMed |
| Venous Thromboembolism Risk Associated With Relugolix-estradiol-norethisterone Acetate Combination Therapy. | J Endocr Soc | 2026 | 41623901 | PubTator, text mining | PubMed |
| Effects of silybin on triptorelin-induced bone metabolic abnormalities in prostate cancer revealed based on TMT-based proteomics. | PLoS One | 2026 | 41610125 | PubTator, text mining | PubMed |
| Single-cell and machine learning approaches reveal METTL14-mediated autophagy via PI3K/AKT signaling in invasive PitNET. | Cancer Cell Int | 2026 | 41588537 | PubTator, text mining | PubMed |
| A novel luteinizing hormone-releasing hormone (LHRH) receptor-targeting peptide LHRH-III': Design and application for targeted breast cancer therapy. | Eur J Med Chem | 2026 | 41518959 | PubTator, text mining | PubMed |
| Salivary proteomics in patients with fixed orthodontic appliances and Invisalign treatment. | Int Dent J | 2026 | 41207115 | PubTator, text mining | PubMed |
| Reversal of Congenital Hypogonadotropic Hypogonadism. | J Clin Endocrinol Metab | 2026 | 41206002 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2798/papers?page=2